1st Counsel – Lifestyle
Author:
Vera Therapeutics
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 27, 2026
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer
March 25, 2026
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 6, 2026
Vera Therapeutics Appoints Christopher Hite to Board of Directors
March 5, 2026